These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3476045)
1. A kinetic study of sulindac in the elderly. Bayley N; Warne RW; Moulds RF; Bury RW Aust N Z J Med; 1987 Feb; 17(1):39-42. PubMed ID: 3476045 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of graded oral doses of sulindac in man. Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116 [TBL] [Abstract][Full Text] [Related]
3. Sulindac oxidation/reduction by microbial cultures; microbial models of mammalian metabolism. Davis PJ; Guenthner LE Xenobiotica; 1985 Oct; 15(10):845-57. PubMed ID: 4072250 [TBL] [Abstract][Full Text] [Related]
4. Sulindac disposition when given once and twice daily. Swanson BN; Boppana VK; Vlasses PH; Holmes GI; Monsell K; Ferguson RK Clin Pharmacol Ther; 1982 Sep; 32(3):397-403. PubMed ID: 7049504 [TBL] [Abstract][Full Text] [Related]
5. Effect of dimethyl sulfoxide on sulindac disposition in rats. Swanson BN; Mojaverian P; Boppana VK; Dudash MR Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805 [TBL] [Abstract][Full Text] [Related]
6. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac. Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423 [TBL] [Abstract][Full Text] [Related]
7. Sulindac metabolism: the importance of an intact colon. Strong HA; Warner NJ; Renwick AG; George CF Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521 [TBL] [Abstract][Full Text] [Related]
9. Ibuprofen and sulindac kinetics in alcoholic liver disease. Juhl RP; Van Thiel DH; Dittert LW; Albert KS; Smith RB Clin Pharmacol Ther; 1983 Jul; 34(1):104-9. PubMed ID: 6861431 [TBL] [Abstract][Full Text] [Related]
10. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium. Duggan DE Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018 [TBL] [Abstract][Full Text] [Related]
11. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study. Schnitzler M; Dwight T; Robinson BG Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116 [TBL] [Abstract][Full Text] [Related]
12. Biliary secretion of sulindac and metabolites in man. Dobrinska MR; Furst DE; Spiegel T; Vincek WC; Tompkins R; Duggan DE; Davies RO; Paulus HE Biopharm Drug Dispos; 1983; 4(4):347-58. PubMed ID: 6661513 [TBL] [Abstract][Full Text] [Related]
13. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism. Lin JH; Yeh KC; Duggan DE Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of sulindac. A dynamic old drug. Davies NM; Watson MS Clin Pharmacokinet; 1997 Jun; 32(6):437-59. PubMed ID: 9195115 [TBL] [Abstract][Full Text] [Related]
16. The disposition of sulindac. Duggan DE; Hare LE; Ditzler CA; Lei BW; Kwan KC Clin Pharmacol Ther; 1977 Mar; 21(3):326-35. PubMed ID: 300048 [TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatography of sulindac and its sulphone and sulphide metabolites in plasma. Grgurinovich N J Chromatogr; 1987 Feb; 414(1):211-6. PubMed ID: 3571386 [No Abstract] [Full Text] [Related]
19. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat. Swanson BN; Mojaverian P; Boppana VK J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731 [TBL] [Abstract][Full Text] [Related]
20. The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine. Xie G; Nie T; Mackenzie GG; Sun Y; Huang L; Ouyang N; Alston N; Zhu C; Murray OT; Constantinides PP; Kopelovich L; Rigas B Br J Pharmacol; 2012 Apr; 165(7):2152-66. PubMed ID: 21955327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]